6 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 6, Unknown 2, Active not recruiting 1, Not yet recruiting 1 |
Follow Yellow Fever: new trials by email Literature Review of Yellow Fever trials Research Report on Yellow Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Single Arm, Open Study on vYF in Adults Yellow fever vaccine (live) - Yellow Fever | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 254 | 2025-10-23 | 2026-02-03 |
| A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population Yellow fever vaccine (live), Measles, combinations with mumps and rubella, live attenuated - Yellow Fever Immunization | Phase 3 | Active not recruiting | Sanofi | 2440 | 2025-07-11 | 2026-11-05 |
| Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults Yellow fever vaccine (live), YF vaccine (live) - Yellow Fever Immunization | Phase 3 | Completed | Sanofi | 640 | 2025-05-22 | 2026-02-02 |
| Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd, Yellow fever Vaccine (WHO prequalified) - Measles, Rubella | Phase 3 | Not yet recruiting | International Centre for Diarrhoeal Disease Research, Bangladesh | 1530 | 2025-04-01 | 2025-02-07 |
| A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL STAMARIL, SII-YFV - Yellow Fever | Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1824 | 2023-05-11 | 2025-05-07 |
| A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants SII Yellow Fever Vaccine, STAMARIL® - Yellow Fever | Phase 3 | Unknown | Serum Institute of India Pvt. Ltd. | 2216 | 2022-09-16 | 2023-11-28 |
| Booster Vaccine for Yellow Fever 17D Yellow fever vaccine - Yellow Fever | Phase 3 | Unknown | London School of Hygiene and Tropical Medicine | 750 | 2022-05-16 | 2022-04-18 |
| A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Typhoid Vi Polysaccharide Vaccine, Yellow Fever Vaccine, Japanese Encephalitis Vaccine - Meningococcal Disease, Meningococcal Meningitis | Phase 3 | Completed | Novartis | 552 | 2011-11-01 | 2014-03-11 |
| Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers Live, attenuated dengue serotype 1, 2, 3, and 4 virus, Yellow fever vaccine, Measles, mumps, and rubella (MMR) vaccine - Dengue, Dengue Hemorrhagic Fever | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 792 | 2011-09-07 | 2022-03-25 |
| The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. Yellow fever vaccination (STAMARIL) - HIV Infection, Yellow Fever | Phase 3 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 71 | 2011-07-01 | 2019-01-18 |
Dengue (1) · Encephalitis, Japanese (1) · Flavivirus Infections (1) · HIV Infections (1) · Measles (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Rabies (1) · Rubella (1) · Severe Dengue (1) · Typhoid Fever (1)
Arbovirus Infections (10) · Flaviviridae Infections (10) · Hemorrhagic Fevers, Viral (10) · Infections (10) · Mosquito-Borne Diseases (10) · RNA Virus Infections (10) · Vector Borne Diseases (10) · Virus Diseases (10) · Flavivirus Infections (9) · Mononegavirales Infections (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Brain Diseases (1) · Central Nervous System Bacterial Infections (1)
Yellow Fever Vaccine (6) · Freeze Drying (1) · Haemophilus Vaccines (1) · Japanese Encephalitis Vaccines (1) · Measles-Mumps-Rubella Vaccine (1) · MenACWY-CRM vaccine (1) · Rabies Vaccines (1) · Sodium Chloride (1) · Tetanus Toxoid (1) · Vaccines (1) · Vi polysaccharide vaccine, typhoid (1)
Sanofi (2) · Sanofi Pasteur, a Sanofi Company (2) · Serum Institute of India Pvt. Ltd. (2) · French National Agency for Research on AIDS and Viral Hepatitis (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · London School of Hygiene and Tropical Medicine (1) · Novartis (1)
Bangladesh (1) · Colombia (1) · Czechia (1) · France (1) · Germany (1) · Honduras (1) · Japan (1) · Kenya (1) · Mali (1) · Mexico (1) · Panama (1) · Peru (1) · The Gambia (1) · United States (1)
PMID 24873986, PMID 25308927, PMID 30096071, PMID 39935766, PMID 42276083
2009 (1), 2014 (1)